Quarterly report · Q2
4360.TEDINET S100S268
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥11.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥12m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥322m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥35m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥474m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥83m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥520m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥61m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥383m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥62m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥383m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥14.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥15.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥14.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.2bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥11.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.6bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥61m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥372m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥210m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥199m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥300m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥27m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥125m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥51m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥7.7 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.8 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥103.26 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.32 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.3 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 76.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥254m |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥270m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥714m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥714m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥33m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.8bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥558m |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E36769-000Fine Chemical Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥126m |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E36769-000Flame Retardants Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥665m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥605m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥605m |
| jpcrp040300-q2r_E36769-000Health Support Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥16m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥808m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 467
| Item | Context | Value | Unit |
|---|---|---|---|
| Depreciation and amortization ope cf | Prior1YTDDuration | 240000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 230000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | 4000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | 29000000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | Prior1YTDDuration | -7000000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | CurrentYTDDuration | － | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -22000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -20000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 0 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 0 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | -48000000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -48000000 | JPY |
| Loss gain on sales and retirement of property plant and equipment ope cf | Prior1YTDDuration | 1000000 | JPY |
| Loss gain on sales and retirement of property plant and equipment ope cf | CurrentYTDDuration | 0 | JPY |
| Subsidy income2 ope cf | Prior1YTDDuration | -56000000 | JPY |
| Subsidy income2 ope cf | CurrentYTDDuration | -0 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 311000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 633000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -996000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -383000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 333000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -415000000 | JPY |
| Other net ope cf | Prior1YTDDuration | 85000000 | JPY |
| Other net ope cf | CurrentYTDDuration | 36000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 366000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 145000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 22000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 20000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -0 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -0 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -72000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -227000000 | JPY |
| Proceeds from subsidy income2 ope cf | Prior1YTDDuration | 56000000 | JPY |
| Proceeds from subsidy income2 ope cf | CurrentYTDDuration | 0 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 372000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -61000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -117000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -359000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 0 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 2000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -0 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -8000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 413000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 160000000 | JPY |
| Other net inv cf | Prior1YTDDuration | 3000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -5000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | 300000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -210000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | 12000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 74000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |